Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alinidine in angina.

T Meinertz, W Kasper, R Meier

    Clinical Pharmacology and Therapeutics
    |December 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    AhR mediates an anti-inflammatory feedback mechanism in human Langerhans cells involving FcεRI and IDO.

    Allergy·2017
    Same author

    [Aspiration of flexor tendon sheath ganglion guided by ultrasonography. An alternative to blind aspiration or surgery?].

    Handchirurgie, Mikrochirurgie, plastische Chirurgie : Organ der Deutschsprachigen Arbeitsgemeinschaft fur Handchirurgie : Organ der Deutschsprachigen Arbeitsgemeinschaft fur Mikrochirurgie der Peripheren Nerven und Gefasse : Organ der V...·2008
    Same author

    Regulation of phosphate transport in proximal tubules.

    Pflugers Archiv : European journal of physiology·2008
    Same author

    Anticoagulation with low-molecular-weight heparin in patients with heart diseases.

    European journal of medical research·2004
    Same author

    [Scapho-trapezio-trapezoid arthrodesis (triscaphe arthrodesis)].

    Handchirurgie, Mikrochirurgie, plastische Chirurgie : Organ der Deutschsprachigen Arbeitsgemeinschaft fur Handchirurgie : Organ der Deutschsprachigen Arbeitsgemeinschaft fur Mikrochirurgie der Peripheren Nerven und Gefasse : Organ der V...·2003
    Same author

    Anticoagulation with the low-molecular-weight heparin dalteparin (Fragmin) in atrial fibrillation and TEE-guided cardioversion.

    Zeitschrift fur Kardiologie·2003
    Same journal

    Clinical Characterization of Enzyme and Transporter Precipitants to Evaluate Drug-Drug Interactions for Orforglipron, a Small Molecule Glucagon-Like Peptide-1 Receptor Agonist.

    Clinical pharmacology and therapeutics·2026
    Same journal

    Symposium Report: Stakeholders' Perspectives on Phase 1 Trials in Japanese Prior to Multi-Regional Clinical Trials and Future Pathways.

    Clinical pharmacology and therapeutics·2026
    Same journal

    Resolving CYP2D6 Structural Complexity with Long-Read Sequencing: Implications for Tamoxifen Precision Dosing in Thai Breast Cancer Patients.

    Clinical pharmacology and therapeutics·2026
    Same journal

    Identification of a Functional CYP2C8 Variant Allele that Alters Splicing, Reduces Protein Expression, and Increases Drug Exposure.

    Clinical pharmacology and therapeutics·2026
    Same journal

    Risk of Hyperkalemia in Patients with Heart Failure Treated with Spironolactone in Combination with Sacubitril/Valsartan vs. Renin-Angiotensin System Inhibitors.

    Clinical pharmacology and therapeutics·2026
    Same journal

    Composite Endpoints in Contemporary Cardiovascular Trials: Trends in Phase 3 Trials and Key Issues in Regulatory Review.

    Clinical pharmacology and therapeutics·2026
    See all related articles

    Alinidine effectively reduced angina symptoms and nitroglycerin use in patients with coronary artery disease. This novel heart rate-lowering drug improved exercise tolerance without beta-adrenergic side effects.

    Area of Science:

    • Cardiology
    • Pharmacology

    Background:

    • Alinidine (N-allyl-clonidine) lowers heart rate without blocking beta-adrenergic receptors.
    • It presents a potential alternative for angina patients avoiding beta-blocker side effects.

    Purpose of the Study:

    • To evaluate the efficacy of alinidine in patients with stable angina and coronary artery disease.

    Main Methods:

    • A 10-week, placebo-controlled, randomized, double-blind trial.
    • Participants received alinidine (40 mg three times daily) or placebo.
    • Evaluated anginal attacks, nitroglycerin use, double product, S-T segment depression, and exercise tolerance.

    Main Results:

    • Alinidine significantly reduced anginal attacks and nitroglycerin consumption.

    Related Experiment Videos

  • A decrease in double product (heart rate x systolic blood pressure) was observed, primarily due to reduced heart rate.
  • Ischemic S-T segment depression diminished, and exercise tolerance improved in most participants.

    • Conclusions:

    • Alinidine demonstrates efficacy in managing stable angina in patients with coronary artery disease.
    • It offers a therapeutic option with a favorable side effect profile compared to beta-blockers.